The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
Open accessAbstract
Background National immunisation programmes globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits of sustaining routine childhood immunisation in Africa with the risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection through visiting routine vaccination service delivery points. Methods We considered a high-impact scenario and a low-impact scenario to approximate the child deaths that could be caused by immunisation coverage reductions during COVID-19 outbreaks. In the high-impact scenario, we used previously reported country-specific child mortality impact estimates of childhood immunisation for diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae , rotavirus, measles, meningitis A, rubella, and yellow fever to approximate the future deaths averted before 5 years of age by routine childhood vaccination during a 6-month COVID-19 risk period without catch-up campaigns. In the low-impact scenario, we approximated the health benefits of sustaining routine childhood immunisation on only the child deaths averted from measles outbreaks during the COVID-19 risk period. We assumed that contact-reducing interventions flattened the outbreak curve during the COVID-19 risk period, that 60% of the population will have been infected by the end of that period, that children can be infected by either vaccinators or during transport, and that upon child infection the whole household will be infected. Country-specific household age structure estimates and age-dependent infection-fatality rates were applied to calculate the number of deaths attributable to the vaccination clinic visits. We present benefit–risk ratios for routine childhood immunisation, with 95% uncertainty intervals (UIs) from a probabilistic sensitivity analysis. Findings In the high-impact scenario, for every one excess COVID-19 death attributable to SARS-CoV-2 infections acquired during routine vaccination clinic visits, 84 (95% UI 14–267) deaths in children could be prevented by sustaining routine childhood immunisation in Africa. The benefit–risk ratio for the vaccinated children is 85 000 (4900–546 000), for their siblings (<20 years) is 75 000 (4400–483 000), for their parents or adult carers (aged 20–60 years) is 769 (148–2700), and for older adults (>60 years) is 96 (14–307). In the low-impact scenario that approximates the health benefits to only the child deaths averted from measles outbreaks, the benefit–risk ratio to the households of vaccinated children is 3 (0·5–10); if the risk to only the vaccinated children is considered, the benefit–risk ratio is 3000 (182–21 000). Interpretation The deaths prevented by sustaining routine childhood immunisation in Africa outweigh the excess risk of COVID-19 deaths associated with vaccination clinic visits, especially for the vaccinated children. Routine childhood immunisation should be sustained in Africa as much as possible, while considering other factors such as logistical constraints, staff shortages, and reallocation of resources during the COVID-19 pandemic. Funding Gavi, the Vaccine Alliance; Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Early dynamics of transmission and control of COVID-19: a mathematical modelling study
Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., Eggo, R. M., Sun, F., Jit, M., Munday, J. D., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30144-4 · Cited by 2,671
Self-citationCoronavirus disease (COVID-19) pandemic.
Rampal, L., & Liew, B. S. (2020) · PubMed · Cited by 2,116
Roberton, T., Carter, E. D., Chou, V. B., Stegmuller, A. R., Jackson, B. D., Tam, Y., Sawadogo-Lewis, T., & Walker, N. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30229-1 · Cited by 1,379
Vaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
(2020) · doi:10.1016/s2214-109x(20)30264-3 · Cited by 1,190
Projecting social contact matrices in 152 countries using contact surveys and demographic data
Prem, K., Cook, A. R., & Jit, M. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005697 · Cited by 889
Self-citation
Cited by
Roberton, T., Carter, E. D., Chou, V. B., Stegmuller, A. R., Jackson, B. D., Tam, Y., Sawadogo-Lewis, T., & Walker, N. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30229-1 · Cited by 1,379
COVID-19 and resilience of healthcare systems in ten countries
Arsenault, C., Gage, A., Kim, M. K., Kapoor, N. R., Akweongo, P., Amponsah, F., Aryal, A., Asai, D., Awoonor-Williams, J. K., Ayele, W., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01750-1 · Cited by 554
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00077-7 · Cited by 546
Causey, K., Fullman, N., Sorensen, R. J. D., Galles, N. C., Zheng, P., Aravkin, A., Danovaro-Holliday, M. C., Martinez-Piedra, R., Sodha, S. V., Velandia-González, M. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01337-4 · Cited by 450
Shet, A., Carr, K., Danovaro-Holliday, M. C., Sodha, S. V., Prosperi, C., Wunderlich, J., Wonodi, C., Reynolds, H. W., Mirza, I., Gacic-Dobo, M., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00512-x · Cited by 363
Metadata
- Authors
- Abbas, K., Procter, S. R., van Zandvoort, K., Clark, A., Funk, S., Mengistu, T., Hogan, D., Dansereau, E., Jit, M., Flasche, S., Houben, R. M. G. J., Edmunds, W. J., Villabona-Arenas, C. J., Atkins, K. E., Knight, G. M., Sun, F. Y., Auzenbergs, M., Rosello, A., Klepac, P., Hellewell, J., Russell, T. W., Tully, D. C., Emery, J. C., Gibbs, H. P., Munday, J. D., Quilty, B. J., Diamond, C., Pearson, C. A. B., Leclerc, Q. J., Nightingale, E. S., Liu, Y., Endo, A., Deol, A. K., Kucharski, A. J., Abbott, S., Jarvis, C. I., O'Reilly, K., Jombart, T., Gimma, A., Bosse, N. I., Prem, K., Hué, S., Davies, N. G., Eggo, R. M., Clifford, S., & Medley, G.
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 8
- Issue
- 10
- Pages
- e1264-e1272
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W3042434201
- Cited by
- 362
- References
- 23
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. https://app.cochat.ai/papers/10.1016/s2214-109x(20)30308-9
- The paper
- Abbas, K., Procter, S. R., van Zandvoort, K., Clark, A., Funk, S., Mengistu, T., Hogan, D., Dansereau, E., Jit, M., Flasche, S., Houben, R. M. G. J., Edmunds, W. J., Villabona-Arenas, C. J., Atkins, K. E., Knight, G. M., Sun, F. Y., Auzenbergs, M., Rosello, A., Klepac, P., . . . Medley, G. (2020). Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(20)30308-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.